Heart disease causing embolism: Prevention of thromboembolism complications caused by atrial fibrillation, mitral valve disease, artificial valve.
Myocardial infarction: Prevention of thromboembolism complications in myocardial infarction such as thrombus adherent to cardiac wall, severe left ventricular dysfunction, left ventricular dysrhythmia causing embolism follow-up therapy alternative to heparin; Prevention of recurrence as alternative aspirin.
Treatment of deep vein thrombosis and pulmonary embolism and prevention of recurrence as alternative to heparin.
Prevention of venous thrombosis and pulmonary embolism in hip surgery.
Prevention of catheter-related thrombosis.

This is only the preview. Please check here for the full indication.

Anatomical Therapeutic Chemical: B
Dosage form: Tablet
Packaging: 10's x 6
Therapeutic area: Active pharmaceutical ingredient: